Business Wire

The newsfeed available here is provided by our content partner Business Wire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public. Business Wire is a subsidiary of the Warren Buffett Group Berkshire Hathaway.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
System-State: Number of processed items 15.977 Notifications successully processed since Inception
Business Wire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
State: 17.11.2024 | 6PM
Fri, 09.08.2024       Merck & Co.
US58933Y1055

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire CN201, a novel investigational clinical-stage bispecific ant...
Read More
Merck & Co.
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Mobileye Global
US60741F1049

Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) announced today that it is scheduled to participate in the following upcoming investor events in the third quarter of 2024. Canaccord Genuity 44th Annual Growth Conference, August 13-15, 2024 Goldman Sachs Communacopia + Technology Conference, San Francisco, September 9-12, 2024 Evercore IS...
Read More
Mobileye Global
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Global Blue Group
CH0562152865

A sustained performance in Continental Europe for international shopping In Continental Europe, the issued Sales in Store growth rate grew by +12%1 in July 2024 vs. last year. This growth was led by a +10%1 increase in the number of shoppers and a +2%1 average spend per shopper. The deceleration in July’s growth rate (+12% in July vs. +19% in ...
Read More
Global Blue Group
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Amneal Pharma
US03168L1052

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) announced its results today for the second quarter ended June 30, 2024. “Amneal achieved strong revenues and adjusted EBITDA in the second quarter, and we are pleased to raise full year 2024 guidance driven by broad-based growth across our business. Amneal is a diversified a...
Read More
Amneal Pharma
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Lululemon Athletica
US5500211090

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of lululemon athletica inc. (NASDAQ: LULU) securities between December 7, 2023 and July 24, 2024, inclusive (the “Class Period”), have until October 7, 2024 to seek appointment as lead plaintiff of the lululemon class action lawsuit. Captioned Patel v. lulu...
Read More
Lululemon Athletica
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       National HealthCare
US6359061008

National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended June 30, 2024 totaled $300,658,000 compared to $282,582,000 for the quarter ended June 30, 2023, an increase of 6.4%. Excluding the governmental stimulus...
Read More
National HealthCare
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Emera
CA2908761018

Today Emera Inc. (“Emera”) (TSX: EMA) reported financial results for the second quarter and year-to-date 2024. Highlights Growth in Reported Net Income Per Share (“EPS”)(1): Reported EPS saw a substantial increase of $0.35 to $0.45 in Q2 2024, compared to $0.10 in Q2 2023. This improvement was driven by a gain on the strategic sale of the Lab...
Read More
Emera
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Li-Cycle
CA50202P1053

Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery company, announced today that the Audit Committee of the Company’s Board of Directors (the “Board”) has unanimously approved the selection of Marcum Canada LLP (“Marcum”) as the Company’s independent registered public accounti...
Read More
Li-Cycle
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       FREYR Battery
LU2360697374

FREYR Battery, Inc. (NYSE: FREY) (“FREYR” or the “Company”), a developer of sustainable, next-generation battery solutions, today reported financial results for the second quarter of 2024. Key Messages: FREYR’s new Board of Directors and leadership team executing plan to achieve first revenues and EBITDA as soon as 2025. The Company’s top pri...
Read More
FREYR Battery
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Mind Medicine
CA60255C8850

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subject to market conditions, common shares and, to certain investors, pre-funded warrants to purchase common sh...
Read More
Mind Medicine
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Anaergia
CA03253E1079

Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX: ANRG) today announced its financial results for the three- and six-month periods ended June 30, 2024 (“Q2 2024”), and the related management’s discussion and analysis (“MD&A”) for the period. Certain highlights from these financial results and from the MD&A follow. All financi...
Read More
Anaergia
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       New York City
US6494393043

American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenue was stable at $15.8 million...
Read More
New York City
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024

Following Olympic gold medalists Pan Zhanle and Zheng Qinwen, the Chinese Artistic Swimming Team has made history by winning China's first-ever Olympic gold medal in artistic swimming! This historic breakthrough has ignited a wave of national pride and excitement, with millions of Chinese celebrating this momentous victory. This press release fea...
Read More
Permalink
Fri, 09.08.2024       Iteris
US46564T1079

Iteris, Inc. (NASDAQ: ITI) (“Iteris” or the “Company”), the world’s trusted technology ecosystem for smart mobility infrastructure management, today announced that it has entered into a definitive merger agreement to be acquired by Almaviva S.p.A. (“Almaviva”), a private Italian digital innovation group, in an all-cash transaction valuing Iteris a...
Read More
Iteris
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Guidewire Software
US40171V1008

Guidewire (NYSE: GWRE) announced that Guidewire India, the company’s software development hub, has launched Guidewire Gives Back’s “ElevatEd by Guidewire” scholarship program in engineering exclusively for female college students from underprivileged backgrounds. “ElevatEd by Guidewire” is a transformative opportunity for talented, disadvantaged...
Read More
Guidewire Software
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       XPEL
US98379L1008

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of XPEL, Inc. (NASDAQ: XPEL) between November 8, 2023 and May 2, 2024. XPEL describes itself as a company that “supplies automotive paint protection film, automotive window film, ceramic coatings, architect...
Read More
XPEL
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the first fiscal quarter of 2025 ended June 30, 2024. Q1 FY2025 Company’s Highlights On April 9, 2024, the Company welcomed Pablo Arbelaez, Ph.D., a renowned AI expert and researcher, to support the development of the Phase 2 clinical tria...
Read More
Permalink
Fri, 09.08.2024       Slate Office Reit
CA8310211005

Slate Office REIT (TSX: SOT.UN) (the "REIT"), an owner and operator of high-quality workplace real estate, reported today financial results and highlights for the three and six months ended June 30, 2024. To access the REIT's Management Discussion and Analysis (MD&A), please follow the link here. Highlights The REIT completed 381,595 sq...
Read More
Slate Office Reit
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Customers Bancorp
US23204G1004

Shares of Customers Bancorp, Inc. (NYSE: CUBI) dropped over 14% in intraday trading on Thursday, August 8, 2024, after the Federal Reserve Board announced that it had issued an enforcement action with Customers Bancorp and its principal subsidiary, citing “significant deficiencies related to the Bank’s risk management practices and compliance with...
Read More
Customers Bancorp
Technical Analysis Termsheet Terminal
Permalink
Fri, 09.08.2024       Outset Medical
US6901451079

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset” or “the Company”) (NASDAQ: OM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to di...
Read More
Outset Medical
Technical Analysis Termsheet Terminal
Permalink

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.